BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7444796)

  • 21. Malformations of the maxillofacial region induced by retinoids in an experimental system.
    Granström G; Kullaa-Mikkonen A; Zellin G
    Int J Oral Maxillofac Surg; 1990 Jun; 19(3):167-71. PubMed ID: 2114463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice.
    Wei X; Sulik KK
    Am J Med Genet; 1993 Nov; 47(6):862-71. PubMed ID: 8279484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural tube defects: an experimental model in the foetal rat.
    Diez-Pardo JA; Mariño JM; Baoquan Q; Delgado-Baeza E; Fernáneez A; Morales MC; Tovar JA
    Eur J Pediatr Surg; 1995 Aug; 5(4):198-202. PubMed ID: 7577855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teratogenic effects of vigabatrin in TO mouse fetuses.
    Abdulrazzaq YM; Bastaki SM; Padmanabhan R
    Teratology; 1997 Mar; 55(3):165-76. PubMed ID: 9181670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teratogenic effects of retinoic acid in pigtail monkeys (Macaca nemestrina). II. Craniofacial features.
    Newell-Morris L; Sirianni JE; Shepard TH; Fantel AG; Moffett BC
    Teratology; 1980 Aug; 22(1):87-101. PubMed ID: 7444803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice.
    Cipollone D; Carsetti R; Tagliani A; Rosado MM; Borgiani P; Novelli G; D'Amati G; Fumagalli L; Marino B; Businaro R
    Cardiovasc Pathol; 2009; 18(2):100-9. PubMed ID: 18417366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorodeoxyuridine-induced malformations in mice. Studies on the early stages of teratogenesis.
    Bro-Rasmussen F; Jensen B; Hansen OM; Ostergaard AH
    Acta Pathol Microbiol Scand A; 1971; 79(1):55-60. PubMed ID: 4251062
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
    Stump DG; Holson JF; Fleeman TL; Nemec MD; Farr CH
    Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethanol-induced teratogenesis: free radical damage as a possible mechanism.
    Kotch LE; Chen SY; Sulik KK
    Teratology; 1995 Sep; 52(3):128-36. PubMed ID: 8638252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology, pathogenesis and prevention of neural tube defects.
    Padmanabhan R
    Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of high doses of retinoic acid on prenatal craniofacial development in Macaca nemestrina.
    Yip JE; Kokich VG; Shepard TH
    Teratology; 1980 Feb; 21(1):29-38. PubMed ID: 6770484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos.
    Fisher MC; Zeisel SH; Mar MH; Sadler TW
    Teratology; 2001 Aug; 64(2):114-22. PubMed ID: 11460263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.
    Patil RD; Dwivedi P; Sharma AK
    Reprod Toxicol; 2006 Nov; 22(4):679-87. PubMed ID: 16781114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
    Ognio E; Lapide M; Ottone M; Mandys V; Peterka M; Parodi B; Viale M
    Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Central nervous system malformations in a Clinical Hospital of Universidad de Chile and in Chilean maternity hospitals that participated in the Latin American Collaborative Study of Congenital Malformations (ECLAMC)].
    Nazer J; Cifuentes L; Rodríguez M; Rojas M
    Rev Med Chil; 2001 Oct; 129(10):1163-70. PubMed ID: 11775343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arachidonic acid reversal of phenytoin-induced neural tube and craniofacial defects in vitro in mice.
    Kay ED; Goldman AS; Daniel JC
    J Craniofac Genet Dev Biol; 1988; 8(2):179-86. PubMed ID: 3141453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos.
    Wlodarczyk BJ; Cabrera RM; Hill DS; Bozinov D; Zhu H; Finnell RH
    Neurotoxicology; 2006 Jul; 27(4):547-57. PubMed ID: 16620997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methanol-induced neural tube defects in mice: pathogenesis during neurulation.
    Bolon B; Welsch F; Morgan KT
    Teratology; 1994 Jun; 49(6):497-517. PubMed ID: 7747271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associated malformations in infants and fetuses with upper or lower neural tube defects.
    Kälién B; Robert E; Harris J
    Teratology; 1998 Feb; 57(2):56-63. PubMed ID: 9562677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.